Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vulva Squamous Cell Carcinoma”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Not applicableStudy completedNCT00315159
What this trial is testing

Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients.

Who this might be right for
Vulvar Cancer
Women and Infants Hospital of Rhode Island 74
Not applicableUnknownNCT04761146
What this trial is testing

A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer

Who this might be right for
Vulva Cancer, RecurrentVulvar Squamous Cell CarcinomaVulva Cancer
CCTU- Cancer Theme 10
Not applicableNot Yet RecruitingNCT06911801
What this trial is testing

In Vitro Study of [18F]F-FAPI-74 Feasibility in Vulvar Cancer

Who this might be right for
Vulvar Squamous Cell Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 90
Not applicableLooking for participantsNCT06039111
What this trial is testing

Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma

Who this might be right for
Vulvar Cancer
Hamilton Health Sciences Corporation 58
Testing effectiveness (Phase 2)Looking for participantsNCT04192253
What this trial is testing

Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize)

Who this might be right for
Locally Advanced, Squamous Cell Carcinoma of the Vulva
The Netherlands Cancer Institute 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07679841
What this trial is testing

Safety and Efficacy of Nivolumab and Imiquimod Combination in Vulvar Squamous Cell Carcinoma Patients

Who this might be right for
Vulvar Squamous Cell Carcinoma
Centre Leon Berard 50
Testing effectiveness (Phase 2)Looking for participantsNCT05686226
What this trial is testing

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Who this might be right for
Cervical CancerThroat CancerOropharynx Cancer+18 more
Christian Hinrichs 20
Testing effectiveness (Phase 2)Study completedNCT03212469
What this trial is testing

A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaLung CancerOesophageal Cancer
Gustave Roussy, Cancer Campus, Grand Paris 54
Not applicableLooking for participantsNCT05576831
What this trial is testing

STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision

Who this might be right for
Vulvar Cancer
British Columbia Cancer Agency 249
Not applicableTemporarily pausedNCT02223975
What this trial is testing

Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease

Who this might be right for
Normal Vulval SkinLichen SclerosusHigh Grade Dysplasia - Usual Type ('VIN 2-3')+5 more
Gloucestershire Hospitals NHS Foundation Trust 200
Testing effectiveness (Phase 2)Study completedNCT00014599
What this trial is testing

Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva

Who this might be right for
Vulvar Cancer
European Organisation for Research and Treatment of Cancer - EORTC 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Looking for participantsNCT04161664
What this trial is testing

Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy

Who this might be right for
Metastatic Squamous Cell Carcinoma of the Vulva
The Netherlands Cancer Institute 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Who this might be right for
Appendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more
M.D. Anderson Cancer Center 133
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Early research (Phase 1)Looking for participantsNCT05952947
What this trial is testing

HRYZ-T101 Injection for HPV18 Positive Solid Tumor

Who this might be right for
Cervical CancerHead and Neck Squamous Cell CarcinomaCarcinoma of Vagina+3 more
HRYZ Biotech Co. 32
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07804966
What this trial is testing

Sac-TMT in Vaginal and Vulvar Cancers

Who this might be right for
Vaginal Squamous Cell CarcinomaVulvar Squamous Cell Carcinoma
Latin American Cooperative Oncology Group 48
Early research (Phase 1)Looking for participantsNCT07217171
What this trial is testing

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Who this might be right for
Bladder CancerSquamous Cell Carcinoma of the LungEsophageal Squamous Cell Carcinoma+8 more
EvolveImmune United, Inc 160
Testing effectiveness (Phase 2)UnknownNCT03221400
What this trial is testing

PEN-866 in Patients With Advanced Solid Malignancies

Who this might be right for
CarcinomaEndometrial AdenocarcinomaNeoplasms+16 more
Tarveda Therapeutics 340
Next Page